Brian Mann
-
More than 200 Americans are dying from drug overdoses daily. Now the Biden administration faces criticism for reportedly delaying a Trump administration policy widely seen as a way to help save lives.
-
The change means that doctors will no longer need a special federal waiver in order to prescribe buprenorphine, a medication to treat opioid use disorder.
-
The evidence is strong that some people struggling with meth addiction benefit from the drug regimen.
-
Researchers say they have identified the first medical treatment that shows promise in helping some people recovering from methamphetamine addiction.
-
The giant retailer shipped billions of opioid pills to pharmacies nationwide. An NPR investigation found employees warned company executives their stores were being used by "pill mill" doctors.
-
Thursday's hearing was the first time members of the Sackler family faced a public accounting for their alleged role in the nation's deadly opioid epidemic.
-
The corporate consulting giant issued a rare apology for its behind-the-scenes work with Purdue Pharma, maker of OxyContin. One senator called McKinsey's behavior "abhorrent."
-
"Ten may even be a bit too much," Dr. Anthony Fauci said, warning that family gatherings through the holidays could lead to "a really dark time" by mid-January.
-
A new plea deal with the Justice Department is the second time the family-owned company admitted criminal schemes to boost Oxycontin sales. Despite their hands-on role, the Sacklers face no charges.
-
The controversial deal hashed out between the Department of Justice and the maker of Oxycontin provides hundreds of millions of dollars of relief for communities hit hard by the opioid epidemic.